Stocks
Eli Lilly and Company (LLY) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 6 899 | 8 913 | 8 043 | 8 661 | 8 568 | 12 514 | ||
| Changes by years, y/y, % | -28% | +29% | -10% | +8% | -1% | -2.3% | |||
Eli Lilly and Company. EBITDA US GAAP, bln rub
Eli Lilly and Company. EBITDA US GAAP, changes, %
Eli Lilly and Company. EBITDA US GAAP, sum by quarters, bln rub
Eli Lilly and Company (LLY) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 962.8 | 3 035 | 3 116 | 4 115 | 2 248 | 12 514 | |
| Changes by years, y/y, % | -60% | +27% | +83% | +77% | +133% | |||
| Changes by quarters, q/q, % | -58% | +215% | +3% | +32% | -45% | |||
